Martine Rothblatt's Securities Transactions in United Therapeutics Corp

The filing details the securities transactions of Martine Rothblatt, the Founder, Chairperson, and Chief Executive Officer of United Therapeutics Corp. The transactions include the sale of common shares over the past three months, with a total of 104,000 shares sold. The sales occurred between September 9, 2025, and October 14, 2025, with gross proceeds ranging from $1,581,535.70 to $3,188,374.33 per transaction. Additionally, the filing mentions the acquisition of 294,000 common shares on March 15, 2016, as part of an Executive Deferred Compensation plan. The filing provides a comprehensive overview of these transactions, including the dates, amounts, and values of the securities sold.